A
ALMS
Alumis Inc
21.47
-0.48-2.17%Opening13:25 04/07 EDT
OPEN/PREV CLOSE21.71/21.94
TODAY RANGE21.00-21.71
VOL487.66K
MARKET CAP2.73B
52 WEEK RANGE2.760-30.60
AVG VOL (3M)1.96M
% TURNOVER0.38%
TURNOVER--
P/E (TTM)-7.5008
% RANGE3.24%
EPS(TTM)-2.8617
P/E(FORWARD)-7.4273
P/B7.46
BVPS2.878
DIVIDEND--
P/S93.45
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.83B
SHARES OUTSTANDING127.20M
NEXT EARNINGS05/12-05/18
FREE FLOAT85.33M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·1h ago
Amgen's Thyroid Eye Disease Data Rocks Rival Viridian, Makes It The Better Buy
Simply Wall St·1d ago
Assessing Alumis (ALMS) Valuation After Positive Phase 3 Envudeucitinib Psoriasis Results And NDA Plans
TipRanks·3d ago
Wall Street Analysts Are Bullish on Top Healthcare Picks
Simply Wall St·5d ago
Why Alumis (ALMS) Is Down 8.4% After Positive Phase 3 Psoriasis Data And FDA Filing Plans
Benzinga·03/30 16:54
Why Is Alumis Stock Falling Monday?
TipRanks·03/30 16:08
Alumis falls -16.1%
TipRanks·03/30 15:50
Alumis shares should trade higher on ‘major success’ at AAD, says Ramond James
Dow Jones·03/30 14:22
Alumis Is Maintained at Outperform by Oppenheimer
Benzinga·03/30 14:12
Oppenheimer Maintains Outperform on Alumis, Raises Price Target to $55
Benzinga·03/30 14:03
Expedia To Rally Around 33%? Here Are 10 Top Analyst Forecasts For Monday
Reuters·03/30 12:24
ALUMIS INC. <ALMS.O>: OPPENHEIMER RAISES TARGET PRICE TO $55 FROM $50
Dow Jones·03/30 12:20
Alumis Price Target Maintained With a $38.00/Share by Chardan Capital
Same Industry
Name/Symbol
Change%
Price